Chinese researchers have achieved a significant breakthrough in biopharmaceutical science by developing a method to produce human serum albumin (HSA) from genetically modified rice. This is reported by China Daily, a partner of TV BRICS. In 2024, China consumed over 1,000 tonnes of HSA, with more than two-thirds sourced through imports. This innovative rice-based method… Continue reading China pioneers large-scale production of human serum albumin from rice